Does DAPAGLIFLOZIN Cause Off label use? 891 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 891 reports of Off label use have been filed in association with DAPAGLIFLOZIN (QTERN). This represents 4.2% of all adverse event reports for DAPAGLIFLOZIN.
891
Reports of Off label use with DAPAGLIFLOZIN
4.2%
of all DAPAGLIFLOZIN reports
28
Deaths
310
Hospitalizations
How Dangerous Is Off label use From DAPAGLIFLOZIN?
Of the 891 reports, 28 (3.1%) resulted in death, 310 (34.8%) required hospitalization, and 118 (13.2%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DAPAGLIFLOZIN. However, 891 reports have been filed with the FAERS database.
What Other Side Effects Does DAPAGLIFLOZIN Cause?
Death (2,775)
Diabetic ketoacidosis (1,773)
Acute kidney injury (982)
Nausea (884)
Dehydration (860)
Vomiting (838)
Dizziness (817)
Ketoacidosis (803)
Fatigue (785)
Diarrhoea (769)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which DAPAGLIFLOZIN Alternatives Have Lower Off label use Risk?
DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL
DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN
DAPAGLIFLOZIN vs DAPRODUSTAT
DAPAGLIFLOZIN vs DAPSONE
DAPAGLIFLOZIN vs DAPTOMYCIN